Articles related to MESOTHELIOMA
Highlights in Non–Small Cell Lung Cancer from the IASLC 2023 World Conference on Lung Cancer
This review encompasses nine recent studies in oncology, highlighting the application of innovative therapies and drug combinations in the treatment of lung cancer.
Oncology, Medical November 13th 2023
MARS 2: Chemo Alone May Be Superior to Surgery Plus Chemo in Mesothelioma
Recent findings from the MARS 2 trial challenge traditional treatment protocols for mesothelioma, indicating that chemotherapy alone may offer improved outcomes over combined surgical approaches. Discover why experts are re-evaluating long-standing surgical treatments.
Oncology, Medical September 25th 2023
Clinical Outcomes Associated with Pembrolizumab Monotherapy Among Adults with Diffuse Malignant Peritoneal Mesothelioma
The findings of this retrospective dual-center cohort study of diffuse malignant peritoneal mesothelioma (DMPM) patients suggest that pembrolizumab had clinical activity regardless of PD-L1 status or histology, though patients with nonepithelioid histology may have benefited more. The partial response rate of 21.0% and median OS of 20.9 months in this cohort with 75.0% epithelioid histology call for additional research to identify those most likely to respond to immunotherapy.
Oncology, Medical March 20th 2023